Business Focus: Healthcare Facilities & Services

Sector:  Healthcare Industry:  Healthcare Facilities & Services
See Regulatory Filings on SEC
Company Contact
Address: 1301 Concord Ter
SUNRISE FL 33323-2843
Tel: 1-954-3840175
IR: See website
Key People
Cesar L. Alvarez
Independent Chairman of the Board
Roger J. Medel
Chief Executive Officer, Director
Stephen D. Farber
Chief Financial Officer, Executive Vice President
David A. Clark
Chief Operating Officer
John C. Pepia
Senior Vice President, Chief Accounting Officer
Dominic J. Andreano
Senior Vice President, General Counsel, Secretary
Kevin Smith
Interim Vice President - Advanced Practice Anesthesia
Business Overview
MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of November 26, 2018, the Company's national network consisted of over 4,225 physicians in all 50 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. As of December 31, 2016, the Company had over 1,390 affiliated physicians providing anesthesia care to patients in connection with surgical and other procedures, as well as pain management. As of December 31, 2016, the Company had 270 affiliated physicians providing maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
Financial Overview
For the nine months ended 30 September 2019, MEDNAX Inc revenues increased 2% to $2.61B. Net loss before extraordinary items totaled $1.18B vs. income of $196.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Goodwill impairment increase from $0K to $1.45B (expense), Practice salaries and benefits increase of 4% to $1.86B (expense).
Employees: 7,625 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $4,016M as of Sep 30, 2019
Annual revenue (TTM): $3,541M as of Sep 30, 2019
EBITDA (TTM): $492.35M as of Sep 30, 2019
Net annual income (TTM): -$1,123M as of Sep 30, 2019
Free cash flow (TTM): $301.17M as of Sep 30, 2019
Net Debt Last Fiscal Year: $1,832M as of Sep 30, 2019
Shares outstanding: 84,298,441 as of Oct 25, 2019
Index Membership: S&P 400 Mid Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization